StockNews.com assumed coverage on shares of ARCA biopharma (NASDAQ:ABIO – Free Report) in a report released on Tuesday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. ARCA biopharma Trading Up 3.3 % Shares of NASDAQ:ABIO opened at $1.64 on Tuesday. ARCA biopharma has a one year low of $1.56 and a […]